Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1992 Nov;90(5):1958–1965. doi: 10.1172/JCI116074

Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).

C Sandholzer 1, G Feussner 1, J Brunzell 1, G Utermann 1
PMCID: PMC443258  PMID: 1430218

Abstract

Lipoprotein(a) consists of a low-density lipoprotein containing apolipoprotein (apo) B-100 and of the genetically polymorphic apo(a). It is not known where and how lipoprotein(a) is assembled and whether there exists a precursor for lipoprotein(a). We have determined the phenotype, concentration, and distribution of apo(a) in plasma from patients with lipoprotein lipase (LPL) deficiency (type I hyperlipoproteinemia, n = 14), in apo E 2/2 homozygotes with type III hyperlipoproteinemia (n = 12) and in controls (n = 16). In the two genetic conditions, there is grossly impaired catabolic conversion of apo B-100-containing precursor lipoproteins to low-density lipoproteins. Considering apo(a) type, the plasma concentration of apo(a) was normal in type III patients but significantly reduced in LPL deficiency. Despite the defects in the catabolism of other apo B-containing lipoproteins, the distribution of apo(a) was only moderately affected in both metabolic disorders, with 66.7% (type I) and 74.7% (type III) being present as the characteristic lipoprotein(a) in the density range of 1.05-1.125 g/ml (controls 81.6%). The remainder was distributed between the triglyceride-rich lipoproteins (type I 12.4%, type III 8.5%, controls 4.7%) and the lipid-poor bottom fraction (type I 19.3%, type III 15.3%, controls 12.6%). In all conditions most apo(a) (57-88%) dissociated from the triglyceride-rich lipoproteins upon recentrifugation and was recovered as lipoprotein(a). These data suggest that lipoprotein(a) is not generated from a triglyceride-rich precursor. Lipoprotein(a) may be secreted directly into plasma or may be formed by preferential binding of secreted apo(a) to existing low-density lipoprotein.

Full text

PDF
1958

Images in this article

1961Image
on p.1961
1962Image
on p.1962
1962Image
on p.1962
1962Image
on p.1962

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auwerx J. H., Babirak S. P., Hokanson J. E., Stahnke G., Will H., Deeb S. S., Brunzell J. D. Coexistence of abnormalities of hepatic lipase and lipoprotein lipase in a large family. Am J Hum Genet. 1990 Mar;46(3):470–477. [PMC free article] [PubMed] [Google Scholar]
  2. Babirak S. P., Iverius P. H., Fujimoto W. Y., Brunzell J. D. Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis. 1989 May-Jun;9(3):326–334. doi: 10.1161/01.atv.9.3.326. [DOI] [PubMed] [Google Scholar]
  3. Bersot T. P., Innerarity T. L., Pitas R. E., Rall S. C., Jr, Weisgraber K. H., Mahley R. W. Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages. J Clin Invest. 1986 Feb;77(2):622–630. doi: 10.1172/JCI112345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Budowle B., Giusti A. M., Waye J. S., Baechtel F. S., Fourney R. M., Adams D. E., Presley L. A., Deadman H. A., Monson K. L. Fixed-bin analysis for statistical evaluation of continuous distributions of allelic data from VNTR loci, for use in forensic comparisons. Am J Hum Genet. 1991 May;48(5):841–855. [PMC free article] [PubMed] [Google Scholar]
  5. Demant T., Carlson L. A., Holmquist L., Karpe F., Nilsson-Ehle P., Packard C. J., Shepherd J. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res. 1988 Dec;29(12):1603–1611. [PubMed] [Google Scholar]
  6. Duvic C. R., Smith G., Sledge W. E., Lee L. T., Murray M. D., Roheim P. S., Gallaher W. R., Thompson J. J. Identification of a mouse monoclonal antibody, LHLP-1, specific for human Lp(a). J Lipid Res. 1985 May;26(5):540–548. [PubMed] [Google Scholar]
  7. Ehnholm C., Mahley R. W., Chappell D. A., Weisgraber K. H., Ludwig E., Witztum J. L. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc Natl Acad Sci U S A. 1984 Sep;81(17):5566–5570. doi: 10.1073/pnas.81.17.5566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fless G. M., Pfaffinger D. J., Eisenbart J. D., Scanu A. M. Solubility, immunochemical, and lipoprotein binding properties of apoB-100-apo[a], the protein moiety of lipoprotein[a]. J Lipid Res. 1990 May;31(5):909–918. [PubMed] [Google Scholar]
  9. Fless G. M., Rolih C. A., Scanu A. M. Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. J Biol Chem. 1984 Sep 25;259(18):11470–11478. [PubMed] [Google Scholar]
  10. Fless G. M., Snyder M. L., Scanu A. M. Enzyme-linked immunoassay for Lp[a]. J Lipid Res. 1989 May;30(5):651–662. [PubMed] [Google Scholar]
  11. Gaubatz J. W., Ghanem K. I., Guevara J., Jr, Nava M. L., Patsch W., Morrisett J. D. Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]. J Lipid Res. 1990 Apr;31(4):603–613. [PubMed] [Google Scholar]
  12. Gaubatz J. W., Heideman C., Gotto A. M., Jr, Morrisett J. D., Dahlen G. H. Human plasma lipoprotein [a]. Structural properties. J Biol Chem. 1983 Apr 10;258(7):4582–4589. [PubMed] [Google Scholar]
  13. Goldberg I. J., Le N. A., Paterniti J. R., Jr, Ginsberg H. N., Lindgren F. T., Brown W. V. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest. 1982 Dec;70(6):1184–1192. doi: 10.1172/JCI110717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gries A., Nimpf J., Nimpf M., Wurm H., Kostner G. M. Free and Apo B-associated Lpa-specific protein in human serum. Clin Chim Acta. 1987 Apr 15;164(1):93–100. doi: 10.1016/0009-8981(87)90110-0. [DOI] [PubMed] [Google Scholar]
  15. Havel R. J. The formation of LDL: mechanisms and regulation. J Lipid Res. 1984 Dec 15;25(13):1570–1576. [PubMed] [Google Scholar]
  16. Kamboh M. I., Ferrell R. E., Kottke B. A. Expressed hypervariable polymorphism of apolipoprotein (a). Am J Hum Genet. 1991 Nov;49(5):1063–1074. [PMC free article] [PubMed] [Google Scholar]
  17. Koschinsky M. L., Tomlinson J. E., Zioncheck T. F., Schwartz K., Eaton D. L., Lawn R. M. Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells. Biochemistry. 1991 May 21;30(20):5044–5051. doi: 10.1021/bi00234a029. [DOI] [PubMed] [Google Scholar]
  18. Kostner G. M., Grillhofer H. K. Lipoprotein(a) mediates high affinity low density lipoprotein association to receptor negative fibroblasts. J Biol Chem. 1991 Nov 5;266(31):21287–21292. [PubMed] [Google Scholar]
  19. Kraft H. G., Menzel H. J., Hoppichler F., Vogel W., Utermann G. Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest. 1989 Jan;83(1):137–142. doi: 10.1172/JCI113849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kraft H. G., Sandholzer C., Menzel H. J., Utermann G. Apolipoprotein (a) alleles determine lipoprotein (a) particle density and concentration in plasma. Arterioscler Thromb. 1992 Mar;12(3):302–306. doi: 10.1161/01.atv.12.3.302. [DOI] [PubMed] [Google Scholar]
  21. Kratzin H., Armstrong V. W., Niehaus M., Hilschmann N., Seidel D. Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. Biol Chem Hoppe Seyler. 1987 Dec;368(12):1533–1544. doi: 10.1515/bchm3.1987.368.2.1533. [DOI] [PubMed] [Google Scholar]
  22. Krempler F., Kostner G. M., Roscher A., Haslauer F., Bolzano K., Sandhofer F. Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. J Clin Invest. 1983 May;71(5):1431–1441. doi: 10.1172/JCI110896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lackner C., Boerwinkle E., Leffert C. C., Rahmig T., Hobbs H. H. Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest. 1991 Jun;87(6):2153–2161. doi: 10.1172/JCI115248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Menzel H. J., Dieplinger H., Lackner C., Hoppichler F., Lloyd J. K., Muller D. R., Labeur C., Talmud P. J., Utermann G. Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect. J Biol Chem. 1990 Jan 15;265(2):981–986. [PubMed] [Google Scholar]
  25. Pfaffinger D., Schuelke J., Kim C., Fless G. M., Scanu A. M. Relationship between apo[a] isoforms and Lp[a] density in subjects with different apo[a] phenotype: a study before and after a fatty meal. J Lipid Res. 1991 Apr;32(4):679–683. [PubMed] [Google Scholar]
  26. Redgrave T. G., Roberts D. C., West C. E. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem. 1975 May 12;65(1-2):42–49. doi: 10.1016/0003-2697(75)90488-1. [DOI] [PubMed] [Google Scholar]
  27. Rittner C., Goenechea S. Zur Lokalisierung von Ag und Lp durch Dichtegradienten-Ultrazentrifugierung. Z Immunitatsforsch Allerg Klin Immunol. 1969 May;137(5):390–402. [PubMed] [Google Scholar]
  28. Sandholzer C., Boerwinkle E., Saha N., Tong M. C., Utermann G. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest. 1992 Mar;89(3):1040–1046. doi: 10.1172/JCI115645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sandholzer C., Hallman D. M., Saha N., Sigurdsson G., Lackner C., Császár A., Boerwinkle E., Utermann G. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet. 1991 Apr;86(6):607–614. doi: 10.1007/BF00201550. [DOI] [PubMed] [Google Scholar]
  30. Scanu A. M., Fless G. M. Lipoprotein (a). Heterogeneity and biological relevance. J Clin Invest. 1990 Jun;85(6):1709–1715. doi: 10.1172/JCI114625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Trieu V. N., McConathy W. J. Lipoprotein(a) binding to other apolipoprotein B containing lipoproteins. Biochemistry. 1990 Jun 26;29(25):5919–5924. doi: 10.1021/bi00477a006. [DOI] [PubMed] [Google Scholar]
  32. Trieu V. N., Zioncheck T. F., Lawn R. M., McConathy W. J. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins. J Biol Chem. 1991 Mar 25;266(9):5480–5485. [PubMed] [Google Scholar]
  33. Utermann G., Hoppichler F., Dieplinger H., Seed M., Thompson G., Boerwinkle E. Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4171–4174. doi: 10.1073/pnas.86.11.4171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Utermann G., Kraft H. G., Menzel H. J., Hopferwieser T., Seitz C. Genetics of the quantitative Lp(a) lipoprotein trait. I. Relation of LP(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma. Hum Genet. 1988 Jan;78(1):41–46. doi: 10.1007/BF00291232. [DOI] [PubMed] [Google Scholar]
  35. Utermann G., Menzel H. J., Kraft H. G., Duba H. C., Kemmler H. G., Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest. 1987 Aug;80(2):458–465. doi: 10.1172/JCI113093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Utermann G., Steinmetz A., Weber W. Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis. Hum Genet. 1982;60(4):344–351. doi: 10.1007/BF00569216. [DOI] [PubMed] [Google Scholar]
  37. Utermann G. The mysteries of lipoprotein(a). Science. 1989 Nov 17;246(4932):904–910. doi: 10.1126/science.2530631. [DOI] [PubMed] [Google Scholar]
  38. Utermann G., Weisgraber K. H., Weber W., Mahley R. W. Genetic polymorphism of apolipoprotein E: a variant form of apolipoprotein E2 distinguished by sodium dodecyl sulfate--polyacrylamide gel electrophoresis. J Lipid Res. 1984 Apr;25(4):378–382. [PubMed] [Google Scholar]
  39. Ye S. Q., Trieu V. N., Stiers D. L., McConathy W. J. Interactions of low density lipoprotein2 and other apolipoprotein B-containing lipoproteins with lipoprotein(a). J Biol Chem. 1988 May 5;263(13):6337–6343. [PubMed] [Google Scholar]
  40. Zioncheck T. F., Powell L. M., Rice G. C., Eaton D. L., Lawn R. M. Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages. J Clin Invest. 1991 Mar;87(3):767–771. doi: 10.1172/JCI115079. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES